Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diamondback Energy Inc (FANG) vs Tilray Brands Inc (TLRY) Price & Performance

Diamondback Energy IncTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

Diamondback Energy Inc vs Tilray Brands Inc — how do they compare? Diamondback Energy Inc trades at $192.03 (market cap $53.67B), while Tilray Brands Inc trades at $3.54 (market cap $530.54M). The key difference: Diamondback Energy Inc is far larger — about 101.2× Tilray Brands Inc's market cap, and Diamondback Energy Inc pays a 2.3% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Diamondback Energy Inc for 69 Days and Tilray Brands Inc for 31 Days on average.

FANGTLRY
Market Cap
$53.67B$530.54M
Volume
2,250,6449,099,075
Sector
EnergyHealth
52-Week High
$213.69$21.00
52-Week Low
$137.29$3.57
Typical Hold Time
69 Days31 Days
Enterprise Value
$65.83B$684.46M
Dividend Yield
2.3%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Diamondback Energy Inc

Diamondback Energy (FANG) trades at $192.30, up 4.3% today, showing strong momentum near its recent highs. The stock maintains a bullish technical outlook with solid fundamental support from growing revenue and consistent earnings beats. Recent Q2 2026 EPS of $6.48 exceeded expectations by 6.6%, while analyst consensus remains overwhelmingly positive with 90.6% buy ratings and a $231.77 price target. The company's cash flow generation remains robust with $8.76B from operations in 2025, supporting dividend payments and strategic investments.

FANG presents a compelling growth opportunity with strong Permian Basin positioning and improving operational efficiency, though investors should monitor oil price volatility and recent insider selling activity. The stock's current valuation at 36.5x P/E reflects growth expectations, while technical indicators suggest potential resistance near $195-$197 levels. With solid institutional support and positive industry outlook, FANG remains well-positioned for continued upside if execution remains strong.

Tilray Brands Inc

Tilray Brands (TLRY) trades at $3.50, down 5.79% on the day and near its 52-week low. The stock shows bearish technical signals with negative moving averages and recent earnings misses across four consecutive quarters. Despite revenue growth to $821 million in 2025, the company reported a substantial net loss of $2.19 billion, driven by impairment charges and high operating costs. Analyst sentiment remains cautious with 65% hold ratings, though the consensus price target of $65.01 suggests significant potential upside from current levels.

The outlook remains challenging with persistent profitability issues and negative cash flow from operations. Investment opportunity exists if Tilray can achieve projected 2026 revenue growth to $915 million and reduce losses. Key risks include ongoing operational inefficiencies, competitive pressures in the cannabis market, and regulatory uncertainty. The stock's current valuation at 0.44 P/S and 0.33 P/B may attract value investors betting on a turnaround.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FANG
100% Buy0% Sell
Avg holding period · 69 Days
TLRY
54% Buy46% Sell
Avg holding period · 31 Days

Top news

Latest headlines on both assets

About Diamondback Energy Inc

Diamondback Energy is an independent oil and gas producer in the United States. The company operates exclusively in the Permian Basin. At the end of 2021, the company reported net proven reserves of 1.8 billion barrels of oil equivalent. Net production averaged about 375,000 barrels per day in 2021, at a ratio of 60% oil, 20% natural gas liquids, and 20% natural gas.

Read more on FANG →

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY →